ABCB1 and acute lymphoblastic leukemia: Further studies illustrated the role of ABCB1 polymorphisms on ponatinib’s distribution into the cerebrospinal fluid in Philadelphia chromosome-positive ALL patients, thereby revealing ponatinib to be a substrate for ABCB1 [184].